Cas 262610-79-7,[AgC12H6N2(C6H3(CH3O)2)2(C12H6N2(C2C6H5)2)](1+)*BF4(1-)=[AgC12H6N2(C6H3(CH3O)2)2C12H6N2(C2C6H5)2]BF4

262610-79-7

Post Buying Request

Basic information

Product Name: [AgC₁₂H₆N₂(C₆H₃(CH₃O)2)2(C₁₂H₆N₂(C₂C₆H₅)2)]⁽¹⁺⁾*BF₄^(1-)=[AgC₁₂H₆N₂(C₆H₃(CH₃O)2)2C₁₂H₆N₂(C₂C₆H₅)2]BF₄
Synonyms:
CAS NO:262610-79-7
Molecular Formula:
Molecular Weight: 1027.63
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: [AgC₁₂H₆N₂(C₆H₃(CH₃O)2)2(C₁₂H₆N₂(C₂C₆H₅)2)]⁽¹⁺⁾*BF₄^(1-)=[AgC₁₂H₆N₂(C₆H₃(CH₃O)2)2C₁₂H₆N₂(C₂C₆H₅)2]BF₄(CAS DataBase Reference)
NIST Chemistry Reference: [AgC₁₂H₆N₂(C₆H₃(CH₃O)2)2(C₁₂H₆N₂(C₂C₆H₅)2)]⁽¹⁺⁾*BF₄^(1-)=[AgC₁₂H₆N₂(C₆H₃(CH₃O)2)2C₁₂H₆N₂(C₂C₆H₅)2]BF₄(262610-79-7)
EPA Substance Registry System: [AgC₁₂H₆N₂(C₆H₃(CH₃O)2)2(C₁₂H₆N₂(C₂C₆H₅)2)]⁽¹⁺⁾*BF₄^(1-)=[AgC₁₂H₆N₂(C₆H₃(CH₃O)2)2C₁₂H₆N₂(C₂C₆H₅)2]BF₄(262610-79-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 262610-79-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

262610-79-7 Suppliers

Recommended suppliers

262610-79-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 262610-79-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,2,6,1 and 0 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 262610-79:
(8*2)+(7*6)+(6*2)+(5*6)+(4*1)+(3*0)+(2*7)+(1*9)=127
127 % 10 = 7
So 262610-79-7 is a valid CAS Registry Number.

262610-79-7Upstream product

262610-79-7Downstream Products

262610-79-7Relevant academic research and scientific papers

Heteroleptic silver(I) and zinc(II) bis(phenanthroline) complexes

Schmittel, Michael,Ganz, Andrea,Fenske, Dieter,Herderich, Markus

, p. 353 - 359 (2007/10/03)

Using sterically hindered 2,9-diarylphenanthrolines (I) as well as unsubstituted or 4,7-disubstituted phenanthrolines (II) the first preparation of open chain heteroleptic bis(phenanthroline) complexes [M(I)(II)]n+ with M = Ag+ or Zn

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 262610-79-7